Search Results - "Midgard, Håvard"

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

“…HCV reinfection following successful treatment can compromise treatment outcomes. This systematic review assessed the rate of HCV reinfection following…”
Get full text

HCV epidemiology in high-risk groups and the risk of reinfection by Midgard, Håvard, Weir, Amanda, Palmateer, Norah, Lo Re, Vincent, Pineda, Juan A, Macías, Juan, Dalgard, Olav

“…Summary Injecting risk behaviours among people who inject drugs (PWID) and high-risk sexual practices among men who have sex with men (MSM) are important…”
Get full text

Hepatitis C reinfection after sustained virological response by Midgard, Håvard, Bjøro, Benedikte, Mæland, Arild, Konopski, Zbigniew, Kileng, Hege, Damås, Jan K, Paulsen, Jørn, Heggelund, Lars, Sandvei, Per K, Ringstad, Jetmund O, Karlsen, Lars N, Stene-Johansen, Kathrine, Pettersson, John H.-O, Dorenberg, Dagny H, Dalgard, Olav

“…Background & Aims On-going risk behaviour can lead to hepatitis C virus (HCV) reinfection following successful treatment. We aimed to assess the incidence of…”
Get full text

Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial by Midgard, Håvard, Malme, Kristian Braathen, Pihl, Charlotte Meinich, Berg-Pedersen, Riikka Mari, Tanum, Lars, Klundby, Ingvild, Haug, Anne, Tveter, Ida, Bjørnestad, Ronny, Olsen, Inge Christoffer, Finbråten, Ane-Kristine, Dalgard, Olav

“…Abstract Background We aimed to evaluate the efficacy of opportunistic treatment of hepatitis C virus (HCV) infection among hospitalized people who inject…”
Get full text

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe by Fraser, Hannah, Martin, Natasha K., Brummer-Korvenkontio, Henrikki, Carrieri, Patrizia, Dalgard, Olav, Dillon, John, Goldberg, David, Hutchinson, Sharon, Jauffret-Roustide, Marie, Kåberg, Martin, Matser, Amy A., Matičič, Mojca, Midgard, Havard, Mravcik, Viktor, Øvrehus, Anne, Prins, Maria, Reimer, Jens, Robaeys, Geert, Schulte, Bernd, van Santen, Daniela K., Zimmermann, Ruth, Vickerman, Peter, Hickman, Matthew

“…[Display omitted] •Chronic HCV prevalence and treatment rates among PWID vary widely across Europe.•HCV treatment scale-up is required in most sites to reduce…”
Get full text

The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination by Safreed-Harmon, Kelly, Blach, Sarah, Aleman, Soo, Bollerup, Signe, Cooke, Graham, Dalgard, Olav, Dillon, John F, Dore, Gregory J, Duberg, Ann-Sofi, Grebely, Jason, Boe Kielland, Knut, Midgard, Håvard, Porter, Kholoud, Razavi, Homie, Tyndall, Mark, Weis, Nina, Lazarus, Jeffrey V

“…Abstract Cascade-of-care (CoC) monitoring is an important component of the response to the global hepatitis C virus (HCV) epidemic. CoC metrics can be used to…”
Get full text

Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs by Midgard, Håvard, Bjørnestad, Ronny, Egeland, Maren, Dahl, Eivin, Finbråten, Ane‐Kristine, Kielland, Knut B., Blindheim, Martin, Dalgard, Olav

“…Background & Aims New models of HCV care are needed to reach people who inject drugs (PWID). The primary aim was to evaluate HCV treatment uptake among HCV RNA…”
Get full text

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV) by Fadnes, Lars T, Aas, Christer Frode, Vold, Jørn Henrik, Ohldieck, Christian, Leiva, Rafael Alexander, Chalabianloo, Fatemeh, Skurtveit, Svetlana, Lygren, Ole Jørgen, Dalgård, Olav, Vickerman, Peter, Midgard, Håvard, Løberg, Else-Marie, Johansson, Kjell Arne

“…A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of…”
Get full text

Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway by Midgard, Håvard, Ulstein, Kjersti, Backe, Øystein, Foshaug, Tarjei, Sørli, Hanne, Vennesland, Kristin, Nilssen, David, Dahl, Elin Hoffmann, Finbråten, Ane-Kristine, Wüsthoff, Linda, Dalgard, Olav

“…•Successful hepatitis C treatment in people who inject drugs was achieved in 95%.•Reinfection surveillance at 3 months intervals was feasible.•The overall rate…”
Get full text

Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study by Druckrey-Fiskaaen, Karl Trygve, Vold, Jørn Henrik, Madebo, Tesfaye, Midgard, Håvard, Dalgard, Olav, Leiva, Rafael Alexander, Fadnes, Lars T

“…Persons with opioid use disorders (OUD) and persons with substance use disorders (SUD) who inject substances have a reduced life expectancy of up to 25 years…”
Get full text

Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study by Malme, Kristian Braathen, Ulstein, Kjersti, Finbråten, Ane-Kristine, Wüsthoff, Linda Elise Couëssurel, Kielland, Knut Boe, Hauge, Joakim, Dalgard, Olav, Midgard, Håvard

“…•Among 2436 participants with chronic HCV 1118 (45.9%) had received HCV treatment during the study period.•Treatment rates increased significantly during the…”
Get full text

The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients by Shridhar Gulati, Rachna, Wimalanathan, Thakshani, Norheim Andersen, Solveig, Isaksen, Kjetil, Lagging, Martin, Midgard, Håvard, Moghaddam, Amir, Dalgard, Olav

“…Introduction: IFNL4 rs12979860 genotype CC is associated with increased ALT activity and liver stiffness in hepatitis C virus (HCV) genotype (G) 3 infection…”
Get full text

Hepatitis C reinfection in former and active injecting drug users in Belgium by Busschots, Dana, Bielen, Rob, Koc, üzgür M, Heyens, Leen, Verrando, Rita, de Galocsy, Chantal, Van Steenkiste, Christophe, Nevens, Frederik, Midgard, Håvard, Dalgard, Olav, Robaeys, Geert

“…Abstract Background There is currently no systematic screening for hepatitis C (HCV) reinfection in people who inject drugs (PWID) after treatment in Belgium…”
Get full text

Increased hope following successful treatment for hepatitis C infection by Bjøro, Benedikte, Dalgard, Olav, Midgard, Håvard, Verbaan, Hans, Småstuen, Milada Cvancarova, Rustøen, Tone

“…Aims To evaluate hope in hepatitis C patients 9 years after curative treatment with pegylated interferon and ribavirin. Background Successful treatment of…”
Get full text

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs by Grebely, Jason, Bruneau, Julie, Lazarus, Jeffrey V., Dalgard, Olav, Bruggmann, Philip, Treloar, Carla, Hickman, Matthew, Hellard, Margaret, Roberts, Teri, Crooks, Levinia, Midgard, Håvard, Larney, Sarah, Degenhardt, Louisa, Alho, Hannu, Byrne, Jude, Dillon, John F., Feld, Jordan J., Foster, Graham, Goldberg, David, Lloyd, Andrew R., Reimer, Jens, Robaeys, Geert, Torrens, Marta, Wright, Nat, Maremmani, Icro, Norton, Brianna L., Litwin, Alain H., Dore, Gregory J.

“…Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently…”
Get full text

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study by Midgard, Håvard, Hajarizadeh, Behzad, Cunningham, Evan B, Conway, Brian, Backmund, Markus, Bruggmann, Philip, Bruneau, Julie, Bourgeois, Stefan, Dunlop, Adrian, Foster, Graham R, Hellard, Margaret, Robaeys, Geert, Thurnheer, Maria C, Weltman, Martin, Amin, Janaki, Marks, Philippa S, Quiene, Sophie, Dore, Gregory J, Dalgard, Olav, Grebely, Jason

“…Abstract Background The risk of hepatitis C virus (HCV) reinfection due to continued injecting risk behaviours might remain a barrier to HCV treatment among…”
Get full text

How can we achieve WHO's elimination target for hepatitis C incidence? by Øvrehus, Anne Lindebo Holm, Midgard, Håvard

Get more information

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study by Cunningham, Evan B, Hajarizadeh, Behzad, Dalgard, Olav, Amin, Janaki, Hellard, Margaret, Foster, Graham R, Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert, Swan, Tracy, Marks, Philippa S, Quiene, Sophie, Applegate, Tanya L, Weltman, Martin, Shaw, David, Dunlop, Adrian, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Thurnheer, Maria Christine, Dore, Gregory J, Grebely, Jason

“…The aims of this analysis were to investigate treatment completion and adherence among people with ongoing injecting drug use or receiving opioid substitution…”
Get full text

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study by Grebely, Jason, Dalgard, Olav, Cunningham, Evan B, Hajarizadeh, Behzad, Foster, Graham R, Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert, Swan, Tracy, Amin, Janaki, Marks, Philippa S, Quiene, Sophie, Applegate, Tanya L, Weltman, Martin, Shaw, David, Dunlop, Adrian, Hellard, Margaret, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Staehelin, Cornelia, Dore, Gregory J

“…Abstract Background There are few data on treatment for hepatitis C virus (HCV) infection among people with ongoing injecting drug use. This study evaluated…”
Get full text

Liver fibrosis in hepatitis C patients of Pakistani versus Scandinavian origin by Midgard, Håvard, Bang, Christina, Raknerud, Nils, Dalgard, Olav

“…Abstract Objective. The aim of this study was to examine the significance of native country for the stage of liver fibrosis in a population of HCV patients of…”
Get full text